Cocrystal Pharma Inc.

COCP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.22

+$0.01 (+0.83%)

At close: Sep 21, 2026, 3:59 PM ET

$1.19

-$0.03 (-2.46%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.83%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $16.75M

1D Range

1.20 1.23

52W Range

0.76 2.03

Valuation (TTM)

PE -1.58

PB 16.05

EV/EBITDA -1.68

Valuation (NTM)

Forward PE N/A

Forward PEG 0.10

Price Target N/A

Cash Flow

FCF Yield -48.7%

SBC Adj. FCF Yield -50.1%

SBC Impact -2.9%

Margins

Gross Margin 205.8%

Operating Margin -3063.6%

FCF Margin -2470.7%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | -19.9%

Dil EPS 3Y | 5Y 39.7% | 51.9%

FCF 3Y | 5Y 25.6% | 16.7%

Returns

ROA -213.8%

ROE -207.5%

ROIC -423.9%

Financial Health

Net Cash

$2.17M

Current Ratio 1.24

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based te...

Sector Healthcare

Industry Biotechnology

Employees 10

IPO Date Feb 21, 2012

Website www.cocrystalpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 13, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞